These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11887986)

  • 1. Systemic treatment and new developments in advanced prostate cancer.
    Sternberg CN
    Eur J Cancer; 2001 Oct; 37 Suppl 7():S147-57. PubMed ID: 11887986
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of prostate cancer].
    Imre R
    Orv Hetil; 2005 Aug; 146(35):1839-42. PubMed ID: 16187544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diagnosis and treatment of early prostate cancer].
    Kaprin AD; Khalil Farzat M; Gafanov RA; Kostin AA
    Vopr Onkol; 2009; 55(3):382-5. PubMed ID: 19670743
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant medical therapy for prostate cancer.
    Sumey C; Flaig TW
    Expert Opin Pharmacother; 2011 Jan; 12(1):73-84. PubMed ID: 21118060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined treatment of metastatic hormone-resistant prostate cancer].
    Kaprin AD; Gafanov RA; Al'bitskiĭ IA; Fastovets SV
    Vopr Onkol; 2009; 55(4):477-9. PubMed ID: 19947375
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of early chemotherapy for hormone-sensitive prostate cancer: time for CHAARTED.
    Aragon-Ching JB
    Asian J Androl; 2016; 18(3):444-5. PubMed ID: 26510505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for androgen withdrawal prior to radiation and surgery for prostate cancer?
    Oncology (Williston Park); 1997 May; 11(5):738. PubMed ID: 9159797
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neoadjuvant hormone therapy before prostatectomy for cancer localized to the prostate].
    Boccon-Gibod L
    Prog Urol; 1997 Feb; 7(1):97-8. PubMed ID: 9116748
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gene expression profile in hormone refractory prostate cancer].
    Stoss O; Jost N; Czeloth K; Rüschoff J; Henkel T; Albers P
    Urologe A; 2007 Sep; 46(9):1117-9. PubMed ID: 17639295
    [No Abstract]   [Full Text] [Related]  

  • 10. [Hormone therapy of locally advanced and metastatic prostate carcinoma].
    Rübben H
    Praxis (Bern 1994); 2001 Sep; 90(38):1641-4. PubMed ID: 11675917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of advanced prostate cancer].
    Leisinger HJ; Jichlinski P
    Rev Med Suisse Romande; 1999 Jun; 119(6):507-11. PubMed ID: 10422478
    [No Abstract]   [Full Text] [Related]  

  • 12. Metastatic castrate-resistant prostate cancer, dawn of a new age of management.
    Nemr EG
    BJU Int; 2013 Mar; 111(3):E9-E10. PubMed ID: 23444940
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of adjuvant androgen deprivation therapy after radical prostatectomy on the survival of patients with pathological T3b prostate cancer.
    Siddiqui SA; Boorjian SA; Blute ML; Rangel LJ; Bergstralh EJ; Karnes RJ; Frank I
    BJU Int; 2011 Feb; 107(3):383-8. PubMed ID: 21265985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer: the role of hormonal therapy.
    Salesi N; Carlini P; Ruggeri EM; Ferretti G; Bria E; Cognetti F
    J Exp Clin Cancer Res; 2005 Jun; 24(2):175-80. PubMed ID: 16110748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of prostate cancer with hormonal therapy in Europe.
    Miller K; Anderson J; Abrahamsson PA
    BJU Int; 2009 Mar; 103 Suppl 2():2-6. PubMed ID: 19228146
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of advanced prostate cancer.
    Held-Warmkessel J
    Semin Oncol Nurs; 2001 May; 17(2):118-28. PubMed ID: 11383243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Maximal androgen blockade in the treatment of patients with disseminated cancer of the prostate].
    Matveev BP; Bukharkin BV
    Vopr Onkol; 1998; 44(5):537-40. PubMed ID: 9884710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined hormone therapy and radiation therapy for locally advanced prostate cancer.
    Bolla M; Laramas M;
    Crit Rev Oncol Hematol; 2012 Dec; 84 Suppl 1():e30-4. PubMed ID: 21144766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate cancer: No evidence for adjuvant chemotherapy in high-risk disease.
    Albers P
    Nat Rev Urol; 2015 Nov; 12(11):602-3. PubMed ID: 26334083
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of neoadjuvant and adjuvant therapy to prevent or delay recurrence of prostate cancer in patients undergoing radiation treatment for prostate cancer.
    Pisansky TM
    Urology; 2003 Dec; 62 Suppl 1():36-45. PubMed ID: 14747040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.